Chengdu Olymvax Biopharmaceuticals Inc. (SHA:688319)
China · Delayed Price · Currency is CNY 23.27
+0.02 (0.09%)
Oct 28, 2025, 3:00 PM CST
SHA:688319 Market Cap
SHA:688319 has a market cap or net worth of 9.44 billion as of October 28, 2025. Its market cap has increased by 175.80% in one year.
Market Cap
9.44B
Enterprise Value
9.64B
Revenue
668.43M
Ranking
n/a
PE Ratio
152.12
Stock Price
23.27
Market Cap Chart
Since June 8, 2021, SHA:688319's market cap has decreased from 16.17B to 9.44B, a decrease of -41.63%. That is a compound annual growth rate of -11.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2025 | 9.45B | 119.53% |
| Dec 31, 2024 | 4.30B | -32.95% |
| Dec 29, 2023 | 6.42B | 14.17% |
| Dec 30, 2022 | 5.62B | -61.27% |
| Dec 31, 2021 | 14.51B | -10.25% |
| Jun 8, 2021 | 16.17B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 435.31B |
| WuXi AppTec | 306.38B |
| Shenzhen Mindray Bio-Medical Electronics | 267.94B |
| Sichuan Biokin Pharmaceutical | 145.45B |
| Shanghai United Imaging Healthcare | 116.57B |
| Aier Eye Hospital Group | 113.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 109.03B |
| Yunnan Baiyao Group Co.,Ltd | 100.56B |